Product
BCX10013
1 clinical trial
1 indication
Indication
Paroxysmal Nocturnal HemoglobinuriaClinical trial
An Open-Label, Multicenter, Intra-Subject Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Therapeutic Potential of BCX10013 in Subjects With Paroxysmal Nocturnal HemoglobinuriaStatus: Recruiting, Estimated PCD: 2024-08-31